US Stem Cell Inc (USRM)

[Dragon Lady]

Quote, "This may be cached not sure. It showed up in my daily Google Bioheart search results today."

It's 100% for certain cached and OLD. It's from 2010.

https://heartresearch.holy-cross.com/taxonomy/term/1759/disclaimer

That is the link to the actual "blog" from which the cached page's text was taken from and why it didn't format correctly.

Read down to the middle of the page in the link above, it's word for word the exact text of the original link posted here earlier (OLD, 2010) about the trial in the supposed "Fall", supposedly "re-starting". The top of the page says, "THE YEAR IN REVIEW" and says clearly 2010.

From the link above, dated 2010 (down about the middle of the page):

"The year 2010 is drawing to an end and this is an appropriate time to review what has been accomplished in the field of cardiology. As you will see, much of this work has been reviewed extensively in this blog."

"Heart failure has reached epidemic proportions in the United States owing to our aging population and the advances in treating myocardial infarctions. Over 5 million people carry the diagnosis and 550,000 new cases a year occur. In 2001, there were nearly 1 million hospital discharges.



We have multiple therapeutic options which include angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta blockers, cardiac resynchronization, diuretics and since the 1700s, digitalis. Now the latest innovation, stem cell injections.



Bioheart is a biotech company located in Sunrise, Florida. They have developed a process to find and grow skeletal muscle stem cells. We do not yet have a process to biopsy and grow cardiac stem cells. There are several very early stage studies in Europe with progenitor cardiac stem cells but they are still in pilot stage. Bioheart's Marvel study is the third and final step to FDA approval of these cells for the treatment of congestive heart failure. A pilot study and a safety study showed that this treatment was safe with a robust trend to effective. In fact, the first 20 patients of the third study - of which three are from our site - have been studied and also found to have a robust effect.



The process involves taking a biopsy from the leg muscle of patients. This is then sent to Bioheart and processed to find the 6-8 fibroblast stem cells in the biopsy specimen. These cells are then grown out and in 14-21 days become billions of cells. These cells are then given to me to inject in the heart after NOGA mapping shows me the appropriate place. See the blogs of June 22 and / or 29 for details of the NOGA procedure.



We are proud to be the only team in South Florida doing this important work. The study will open for enrollment again in the Fall and we look forward to helping our patients with this technique. Please feel free to contact us for more information at 954-229-8400.

tags:
Bioheart
Enrollment
Heart Failure
Marvel
NOGA
Stem cell injections
Therapeutic options
categories:
Adult Stem / Cell Treatment
Heart Failure"

From 2010, and how did that "work out"??? It's 5 yrs old and it went nowhere, which is typical of BHRT "trials". I doubt Holy Cross hospital has had anything to do with BHRT in about 5 years, nothing. It's old info and related to trials that went dead a long, long, time ago IMO.

That page and "the fall" is clearly referring to the Fall of 2011 which NEVER HAPPENED then as those trials went dead in 2010 (see any SEC 10-K filing of the last 4 years), it's plain as day IMO. The top of the page has an actual date/year on it- and it's 2010.